SABLICH KIM (Chief Commercial Officer) sold 7.5% of their position (4.84K shares) of MYOVANT SCIENCES LTD. on the open market
Open‑market sale worth $68.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/16/2020ACC: 0001209191-20-003741
Officer· Chief Commercial Officer
Since Dec 2018
-4.84K
Net shares
Net seller
$68.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.84K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.84K
Price / share
$14.04
Trade value
$67.95K
% of position
7.5%
1/15/2020
64.53K→59.69K
Total
Net shares
−4.84K
Net value
-$67.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/15/2020 | S · Sale | −4.84K | $14.04 | $67.95K | 7.5% | 64.53K | 59.69K |
| Total | −4.84K | -$67.95K | ||||||
Derivative Transactions0
No derivative transactions reported